Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

PHIO PHARMACEUTICALS CORP.

(PHIO)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news
Most relevant news about PHIO PHARMACEUTICALS CORP.
07/07PHIO PHARMACEUTICALS : Scheduled to Participate in a Fireside Chat with H.C. Wai..
PR
06/22PHIO PHARMACEUTICALS : Reschedules Fireside Chat Hosted by H.C. Wainwright for J..
PR
06/14PHIO PHARMACEUTICALS : Scheduled to Participate in Two Upcoming Investor Events ..
PR
06/14PHIO PHARMACEUTICALS : HC Wainwright Adjusts Phio Pharmaceuticals' Price Target ..
MT
06/07PHIO PHARMACEUTICALS : Presents new in vivo data at the 2021 asco annual meeting..
AQ
06/04PHIO PHARMACEUTICALS' : Study Shows Treatment With Intasyl May Induce Tumor Resp..
MT
06/04Phio Pharmaceuticals Presents New in Vivo Data At the 2021 Asco Annual Meetin..
CI
05/14PHIO PHARMACEUTICALS : Reports first quarter 2021 financial results and provides..
AQ
05/13Phio Pharmaceuticals Corp. Reports Earnings Results for the First Quarter End..
CI
05/12PHIO PHARMACEUTICALS : Presents positive in vivo data at asgct showing ph-762 si..
AQ
05/11Phio Pharmaceuticals Presents Positive In Vivo Data at ASGCT Showing PH-762 S..
CI
04/10PHIO PHARMACEUTICALS : Presents Positive In Vivo Data Showing Strong Tumor Contr..
PR
04/10Phio Pharmaceuticals Corp. Presents Positive in Vivo Data Showing Strong Tumo..
CI
03/25PHIO PHARMACEUTICALS : Reports 2020 Year End Financial Results and Provides Busi..
PR
03/25Phio Pharmaceuticals Corp. Reports Earnings Results for the Full Year Ended D..
CI
03/12PHIO PHARMACEUTICALS : to Present New Data on PD-1 Targeting INTASYL at the 2021..
AQ
03/09PHIO PHARMACEUTICALS : HCW Global Life Sciences 2021 Conference Presentation
PU
03/01PHIO PHARMACEUTICALS : Thinking about buying stock in Phio Pharmaceuticals, SRAX..
PR
03/01PHIO PHARMACEUTICALS : and AgonOx, Inc. Announce Collaboration on Clinical Devel..
PR
03/01Phio Pharmaceuticals and AgonOx Inc. Announces Collaboration on Clinical Deve..
CI
02/23PHIO PHARMACEUTICALS : to Participate in the H.C. Wainwright Global Life Science..
PR
02/18PHIO PHARMACEUTICALS : Thinking about buying stock in Ampio Pharmaceuticals, Mot..
PR
02/17PHIO PHARMACEUTICALS : Announces Closing of $7.7 Million Registered Direct Offer..
PR
02/15PHIO PHARMACEUTICALS : Announces $7.7 Million Registered Direct Offering of Comm..
AQ
02/12PHIO PHARMACEUTICALS : Makes $7.7 Million Registered Direct Offering of At-the-M..
MT
02/12PHIO PHARMACEUTICALS : Announces $7.7 Million Registered Direct Offering of Comm..
PR
01/26PHIO PHARMACEUTICALS : Thinking about buying stock in Phio Pharmaceuticals, Alle..
PR
01/25PHIO PHARMACEUTICALS : Closes $14 Million Private Placement of Almost 4.6 Millio..
MT
01/25PHIO PHARMACEUTICALS : Announces Closing of $14.0 Million Private Placement Pric..
PR
01/25Phio Pharmaceuticals Corp. announced that it has received $14.001908 million ..
CI
01/21PHIO PHARMACEUTICALS : Announces $14.0 Million Private Placement Priced At-the-M..
PR
01/21Phio Pharmaceuticals Corp. announced that it expects to receive $14.001908 mi..
CI
01/04PHIO PHARMACEUTICALS : to Participate in the H.C. Wainwright BioConnect 2021 Con..
PR
2020PHIO PHARMACEUTICALS : Thinking about buying stock in Immersion Corp, IRIDEX Cor..
PR
2020PHIO PHARMACEUTICALS : to Participate in the 3rd Annual Evercore ISI HealthCONx ..
AQ
2020PHIO PHARMACEUTICALS : to Participate in the 3rd Annual Evercore ISI HealthCONx ..
PR
2020PHIO PHARMACEUTICALS : Reports Third Quarter 2020 Financial Results and Provides..
AQ
2020Phio Pharmaceuticals Corp. Reports Earnings Results for the Third Quarter End..
CI
2020PHIO PHARMACEUTICALS : Reports Third Quarter 2020 Financial Results and Provides..
PR
2020PHIO PHARMACEUTICALS : Announces Positive In Vivo Data On Combination PD-1 And T..
PR
2020Phio Pharmaceuticals Corp. Announces Positive in Vivo Data on Combination PD-..
CI
2020PHIO PHARMACEUTICALS : Announces Three Poster Presentations at the 2020 Society ..
AQ
2020PHIO PHARMACEUTICALS : Announces Three Poster Presentations at the 2020 Society ..
PR
2020PHIO PHARMACEUTICALS : to Present at the H.C. Wainwright 22nd Annual Global Inve..
AQ
2020PHIO PHARMACEUTICALS : to Present at the H.C. Wainwright 22nd Annual Global Inve..
PR
2020PHIO PHARMACEUTICALS : Reports Second Quarter 2020 Financial Results and Provide..
AQ
2020Phio Pharmaceuticals Corp. Reports Earnings Results for the Second Quarter En..
CI
2020PHIO PHARMACEUTICALS : to Host Key Opinion Leader Call on Intratumoral Therapy w..
AQ
2020PHIO PHARMACEUTICALS : Announces Positive In Vivo Data on the Intratumoral Use o..
PR
2020Phio Pharmaceuticals Corp. Announces Positive in Vivo Data on the Intratumora..
CI
2020PHIO PHARMACEUTICALS : Presents Data on INTASYL as an Alternative to Genetic Mod..
AQ
2020PHIO PHARMACEUTICALS : Reports First Quarter 2020 Financial Results and Provides..
AQ
2020Phio Pharmaceuticals Corp. Reports Earnings Results for the First Quarter End..
CI
2020Certain Restricted Stock Units of Phio Pharmaceuticals Corp. are subject to ..
CI
2020Certain Warrants of Phio Pharmaceuticals Corp. are subject to a Lock-Up Agree..
CI
2020Certain Stock Options of Phio Pharmaceuticals Corp. are subject to a Lock-Up ..
CI
2020Certain Common Stock of Phio Pharmaceuticals Corp. are subject to a Lock-Up A..
CI
2020PHIO PHARMACEUTICALS : Announces Closing of $4.0 Million Registered Direct Offer..
PR
2020PHIO PHARMACEUTICALS : Announces Positive New Data Validating the INTASYL Immuno..
AQ
2020PHIO PHARMACEUTICALS : Announces $4.0 Million Registered Direct Offering Priced ..
PR
2020PHIO PHARMACEUTICALS : Announces Positive New Data Validating the INTASYL™..
PR
2020PHIO PHARMACEUTICALS : Reports Year End 2019 Financial Results and Provides Busi..
AQ
2020Phio Pharmaceuticals Corp. Reports Earnings Results for the Fourth Quarter En..
CI
2020PHIO PHARMACEUTICALS : Announces Closing of $8.0 Million Underwritten Public Off..
PR
2020PHIO PHARMACEUTICALS : Announces Pricing of $8.0 Million Underwritten Public Off..
PR
2020PHIO PHARMACEUTICALS : Announces Compliance with Nasdaq Listing Requirements
PR
2020PHIO PHARMACEUTICALS : Announces Closing of $1.74 Million Registered Direct Offe..
PR
2020PHIO PHARMACEUTICALS : Announces $1.74 Million Registered Direct Offering Priced..
PR
2020PHIO PHARMACEUTICALS CORP. : REVERSE SPLIT: 1 of 55
FA
2020PHIO PHARMACEUTICALS : Announces Reverse Stock Split
PR
2020PHIO PHARMACEUTICALS : to Present at Biotech Showcase 2020
PR
2019PHIO PHARMACEUTICALS : Announces Adjournment of Special Meeting of Stockholders
AQ
2019PHIO PHARMACEUTICALS : Announces Adjournment of Special Meeting of Stockholders
PR
2019PHIO PHARMACEUTICALS : and Karolinska Institutet Expand Collaboration to Develop..
PR
2019Phio Pharmaceuticals and Karolinska Institutet Expand Collaboration to Develo..
CI
1  2  3Next
Upcoming event on PHIO PHARMACEUTICALS CORP.